Detection of gliotoxin in experimental and human aspergillosis

Infection and Immunity

Volumn 73, Issue 1, 2005, Pages 635-637

  Lewis, Russell E ^a,b   Wiederhold, Nathan P ^a,b   Chi, Jingduan ^a   Han, Xiang Y ^b   Komanduri, Krishna V ^b   Kontoyiannis, Dimitrios P ^a,b   Prince, Randall A ^a,b  

^a UNIVERSITY OF HOUSTON   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; GLIOTOXIN;

ANIMAL MODEL; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BLOOD LEVEL; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; LEUKEMIA; LIQUID CHROMATOGRAPHY; LUNG ASPERGILLOSIS; LUNG CANCER; MASS SPECTROMETRY; MORTALITY; MYCOSIS; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SERUM; SURVIVAL RATE;

AMPHOTERICIN B; ANIMALS; ASPERGILLOSIS; FEMALE; GLIOTOXIN; HUMANS; LUNG; MICE;

EID: 11144311054     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.1.635-637.2005     Document Type: Article

References (17)

1. Ascioglu, S., J. H. Rex, B. de Pauw, J. E. Bennett, J. Bille, F. Crokaert, D. W. Denning, J. P. Donnelly, J. E. Edwards, Z. Erjavec, D. Fiere, O. Lortholary, J. Maertens, J. F. Meis, T. F. Patterson, J. Ritter, D. Selleslag, P. M. Shah, D. A. Stevens, and T. J. Walsh. 2002. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34:7-14.
2. Bauer, J., M. Gareis, A. Bott, and B. Gedek. 1989. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. J. Med. Vet. Mycol. 27:45-50.
3. Bowman, J. C., G. K. Abruzzo, J. W. Anderson, A. M. Flattery, C. J. Gill, V. B. Pikounis, D. M. Schmatz, P. A. Liberator, and C. M. Douglas. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother. 45:3474-3481.
4. Dixon, D. M., A. Polak, and T. J. Walsh. 1989. Fungus dose-dependent primary pulmonary aspergillosis in immunosuppressed mice. Infect. Immun. 57:1452-1456.
5. Lewis, R. E., R. A. Prince, J. Chi, and D. P. Kontoyiannis. 2002. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis. Antimicrob. Agents Chemother. 46:3208-3214.
6. Mullbacher, A., and R. D. Eichner. 1984. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl. Acad. Sci. USA 81: 3835-3837.
7. Mullbacher, A., P. Waring, and R. D. Eichner. 1985. Identification of an agent in cultures of Aspergillus fumigatus displaying anti-phagocytic and immunomodulating activity in vitro. J. Gen. Microbiol. 131:1251-1258.
8. Murayama, T., R. Amitani, V. Ikegami, R. Nawada, W. J. Lee, and F. Kuze. 1996. Suppressive effects of Aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur. Respir. J. 9:293-300.
9. Pahl, H. L., B. Krauss, K. Schulze-Osthoff, T. Decker, E. B. Traenckner, M. Vogt, C. Myers, T. Parks, P. Warring, A. Muhlbacher, A. P. Czernilofsky, and P. A. Baeuerle. 1996. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappa B. J. Exp. Med. 183:1829-1840.
10. Reeves, E. P., T. Murphy, P. Daly, and K. Kavanagh. 2004. Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. J. Med. Microbiol. 53: 719-725.
11. Richard, J. L., T. J. Dvorak, and P. F. Ross. 1996. Natural occurrence of gliotoxin in turkeys infected with Aspergillus fumigatus, Fresenius. Mycopathologia 134:167-170.
12. Tomee, J. F., and H. F. Kauffman. 2000. Putative virulence factors of Aspergillus fumigatus. Clin. Exp. Allergy 30:476-484.
13. Torres, H. A., G. A. Rivero, R. E. Lewis, R. Hachem, I. I. Raad, and D. P. Kontoyiannis. 2003. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus. Diagn. Microbiol. Infect. Dis. 46:25-28.
14. Tsunawaki, S., L. S. Yoshida, S. Nishida, T. Kobayashi, and T. Shimoyama. 2004. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect. Immun. 72:3373-3382.
15. Waring, P., R. D. Eichner, and A. Mullbacher. 1988. The chemistry and biology of the immunomodulating agent gliotoxin and related epipolythiodioxopiperazines. Med. Res. Rev. 8:499-524.
16. Waring, P., R. D. Eichner, A. Mullbacher, and A. Sjaarda. 1988. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J. Biol. Chem. 263:18493-18499.
17. Wichmann, G., O. Herbarth, and I. Lehmann. 2002. The mycotoxins citrinin, gliotoxin, and patulin affect interferon-gamma rather than interleukin-4 production in human blood cells. Environ. Toxicol. 17:211-218.